Barbara Dalton, Ph.D.
Vice President Venture Capital, Worldwide Business Development, Pfizer Inc.
Dr. Dalton is responsible for Pfizer’s Venture Investments, managing the current private equity portfolio and advising on equity transactions. Dr Dalton was a founding member of EuclidSR Partners, a private venture capital firm. She began her business career as a research scientist at SmithKline before moving to their venture capital subsidiary, S.R. One, Limited. Barbara has managed diverse fund and company investments throughout the world. She is an advisor to the Dean of the Penn State Eberly College of Science, where she received her undergraduate degree, and a member of The Penn State Research Foundation Board of Directors. She leads the Healthcare Investing Group of the New York City Investment Fund and is a former member of the Board of Directors of the Alzheimer’s Disease Research Foundation, NY Biotech Association and the National Venture Capital Association. Dr Dalton received her PhD in Immunology and Microbiology from The Medical College of Pennsylvania.